A provider of healthcare products used for screening, detection, treatment, monitoring & tracking of common medical ailments such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders, newborn jaundice & newborn metabolic testing.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Natus Medical is an industry leader that develops products to medically screen babies. According to their last 10Q, they seem to be growing the company pretty well independently of the acquisitions that they've made. They have been busy buying companies that compliment their product line, though, so long term they ought to perform really well. There is a real question of how the stock will do short term while Natus digests the acquisitions. Risky, I think, for anyone interested in only in short term returns.
Apparently the digestion of acquired companies is going quite well. There wont be guidance for 2007 until January because they need to work with some of the new product line and figure out how to change some of it from catalogue sales to direct; but their last 10Q showed earnings way up. Price hasn't followed, but I believe that is becaues analysts are waiting for the FY2007 guidance. Look for a bump up in January.